Brief: Armata Pharmaceuticals Announces Q2 Results And Provides Corporate And Clinical Update
14/08/2019 21:17
Aug 14 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES SECOND QUARTER RESULTS
AND
PROVIDES CORPORATE AND CLINICAL UPDATE
* ARMATA PHARMACEUTICALS - AS OF JUNE 30, ARMATA HELD $13.2
MILLION OF UNRESTRICTED CASH AND EQUIVALENTS AS COMPARED TO $9.7
MILLION AS OF DECEMBER 31, 2018
* ARMATA PHARMACEUTICALS - LOSS FROM OPERATIONS FOR THREE
MONTHS
ENDED JUNE 30, 2019 WAS $5.2 MILLION AS COMPARED TO $2.8 MILLION
FOR COMPARABLE PERIOD IN 2018
Source text for Eikon: ID:nPnbcHNbxa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles